查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826928

2025年全球基因面板市場報告

Gene Panel Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基因檢測市場規模迅速擴張，從2024年的21.4億美元成長到2025年的24.7億美元，複合年成長率為15.2%。預測期內的成長可歸因於遺傳病患病率的上升、基因篩檢需求的增加、研發活動的增加、先天性疾病盛行率的上升以及對先進治療方案的需求的不斷成長。

預計未來幾年基因檢測市場將快速成長，到2029年將達到43.3億美元，年複合成長率（CAGR）為15.1%。預測期內的成長主要受以下因素驅動：慢性病發生率上升、癌症盛行率上升、基因檢測意識增強、政府措施以及醫療支出成長。預測期內的主要趨勢包括基因檢測技術的進步、策略合作、個人化醫療、人工智慧的整合以及先進的生物資訊學工具。

基因面板是一組選定的特定基因，用於在單次檢測中檢測，以分析與特定疾病或病症相關的遺傳變異。基因面板用於遺傳疾病診斷、遺傳疾病檢測，並透過同時檢測多個基因來制定個人化治療方案，特別適用於癌症、罕見疾病和其他遺傳性疾病。

我們主要的基因檢測產品和服務包括檢測套組和檢測服務。檢測套組是包含所有基因分析所需試劑和說明書的包裝工具。這些檢測試劑盒採用擴增子和雜合反應等多種技術，並提供預先設計或客製化版本。我們的檢測試劑盒應用於癌症風險評估、先天性疾病診斷和藥物基因等領域，服務研究機構、醫院、診斷中心和製藥公司等終端用戶。

2025 年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療保健提供者正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品成本的上漲，其中許多產品的國內替代品有限。這些不斷上漲的成本使醫療保健預算捉襟見肘，導致一些醫療機構推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，造成供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供基因面板市場統計數據，例如基因面板行業的全球市場規模、各地區佔有率、各競爭對手的市場佔有率、詳細的基因面板細分市場、市場趨勢和機遇，以及在基因面板行業取得成功所需的數據。本基因面板市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

未來五年15.1%的成長預測較先前的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國，因為這將增加來自韓國和英國的次世代定序的成本，從而延遲遺傳疾病的診斷，並增加分子病理學實驗室的支出。由於互惠關稅以及貿易緊張局勢和限制措施的加劇對全球經濟和貿易的負面影響，其影響也將更加廣泛。

癌症盛行率的上升預計將推動基因面板市場的成長。癌症是一組以異常細胞不受控制地生長和擴散為特徵的疾病，這些細胞會侵入並損害周圍的組織和器官。人口老化、生活方式的改變、環境暴露以及檢測和診斷技術的進步等因素導致癌症患者數量不斷增加。基因面板在癌症診斷中發揮關鍵作用，它可以透過全面的基因檢測來識別特定的基因突變和變異，從而促進個人化治療策略並改善患者預後。例如，2024年2月，總部位於瑞士的政府間組織世界衛生組織（WHO）報告稱，預計2022年將有970萬人死於癌症，並新增2,000萬例癌症病例。肺癌是最常見的癌症，佔新增病例的12.4%，全球確診人數為250萬人。癌症盛行率的上升持續推動基因面板檢測的需求。

基因面板市場的主要企業正致力於開發先進的腫瘤學面板，以提高癌症診斷和個人化治療方法的準確性、效率和全面性。腫瘤學面板是專門的基因面板，可分析多個癌症相關基因並識別基因突變和變異，以輔助診斷、預後和治療計劃。例如，美國生物技術公司Vizgen Inc.於2023年5月推出了MERFISH PanCancer Pathways Panel，為研究太空基因組學的科學家提供可客製化的選項。這些預先設計的面板針對包括癌症研究在內的各種研究應用進行了最佳化，並增強了誤差穩健性，從而獲得可靠且可重複的結果。透過將空間資訊與基因表現數據結合，該面板可以深入了解腫瘤微環境和細胞間相互作用，從而促進靶向癌症研究和治療方法的開發。這項技術創新代表了空間生物學的重大突破，使研究人員能夠以前所未有的細節分析複雜的生物系統。

2022年5月，美國健康情報公司Sema4以3.22億美元收購了GeneDx。此次收購鞏固了Sema4作為美國領先基因組檢測提供者的地位，並增強了其健康資訊資料庫，從而改善患者照護和治療方案的開發。 GeneDx同樣總部位於美國，專注於為罕見遺傳疾病、遺傳性疾病和癌症提供全面的診斷服務，這進一步增強了Sema4在精準醫療領域的能力。

基因檢測面板市場由提供客製化檢測面板設計、次世代定序、生物資訊分析、臨床解讀和藥物基因體學等服務的營業單位所賺取的收益所構成。市場價值包括服務供應商銷售的或包含在其服務產品中的任何相關產品的價值。基因檢測面板市場還包括代謝失調檢測面板、生殖健康檢測面板、攜帶者篩檢面板和神經系統疾病檢測面板的銷售。該市場的價值是指“出廠價”，即產品製造商或生產商銷售的產品價值，無論是銷售給其他營業單位（包括下游製造商、經銷商、分銷商和零售商）或直接銷售給最終客戶。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球基因小組：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球基因組市場：成長率分析
  • 全球基因面板市場表現：規模與成長，2019-2024
  • 全球基因檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球基因面板：總目標市場（TAM）

第6章 市場細分

  • 全球基因組市場（依產品及服務分類）、實際及預測（2019-2024 年、2024-2029 年預測、2034 年預測）
  • 檢測套組
  • 測試服務
  • 全球基因面板市場（依技術分類）：2019-2024 年、2024-2029 年、2034 年表現及預測
  • 基於擴增子
  • 雜交基地
  • 其他技術
  • 全球基因組市場：設計、現況及預測，2019-2024 年、2024-2029 年、2034 年
  • 預先設計的基因組
  • 客製化基因面板
  • 全球基因面板市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症風險評估
  • 先天性疾病的診斷
  • 藥物基因組學
  • 其他用途
  • 全球基因組市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 研究機構
  • 醫院
  • 診斷中心
  • 製藥公司
  • 其他最終用戶
  • 全球基因檢測試劑盒市場：依檢測套件類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 預先設計的基因面板
  • 客製化基因面板
  • 全球基因面板市場：依檢測服務（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症風險評估小組
  • 藥物基因組學測試小組
  • 神經系統疾病專家小組
  • 心血管疾病專家小組
  • 罕見疾病專家組

第7章 區域和國家分析

  • 全球基因面板市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球基因面板市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 基因面板市場：競爭格局
  • 基因組市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Intermountain Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Agilent Technologies Inc.
  • Illumina Inc.
  • Qiagen Inc.
  • OPKO Health Inc.
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Invitae Corp.
  • Integrated DNA Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Novogene Corporation
  • Fulgent Genetics Inc.
  • MedGenome Inc.
  • OriGene Technologies Inc.
  • Centogene AG
  • Blueprint Genetics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年基因檢測市場：哪些國家將提供新機會
  • 2029 年基因檢測市場：細分領域蘊含新機會
  • 2029 年基因面板市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34056u

Gene panels are a set of specific genes selected for testing in a single assay to analyze genetic variations associated with particular diseases or conditions. They are utilized for diagnosing genetic disorders, detecting inherited diseases, and enabling personalized treatment plans by examining multiple genes simultaneously, particularly in cancer, rare diseases, and other genetic conditions.

The primary gene panel products and services include test kits and testing services. Test kits are pre-packaged tools containing all necessary reagents and instructions for genetic analysis. These panels employ various technologies, such as amplicon-based and hybridization-based methods, and can be either predesigned or customized. They are applied in cancer risk assessment, congenital disease diagnosis, pharmacogenetics, and other areas, serving end users such as research institutes, hospitals, diagnostic centers, pharmaceutical companies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The gene panel market research report is one of a series of new reports from The Business Research Company that provides gene panel market statistics, including gene panel industry global market size, regional shares, competitors with a gene panel market share, detailed gene panel market segments, market trends and opportunities, and any further data you may need to thrive in the gene panel industry. This gene panel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene panel market size has grown rapidly in recent years. It will grow from $2.14 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to the rising prevalence of hereditary disorders, growing necessity for genetic screening, increasing research and development activities, rising prevalence of congenital diseases, and increasing demand for advanced treatment options.

The gene panel market size is expected to see rapid growth in the next few years. It will grow to $4.33 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to an increasing number of chronic diseases, increasing cancer cases, increasing awareness of genetic testing, and increasing government initiatives and healthcare spending. Major trends in the forecast period include the advancement of gene panel technology, strategic collaboration, personalized treatment, the integration of artificial intelligence, and advanced bioinformatics tools.

The forecast of 15.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of next-generation sequencing (NGS) gene panels sourced from South Korea and the UK, thereby delaying genetic disease diagnoses and elevating molecular pathology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cancer is expected to drive the growth of the gene panel market. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade and damage surrounding tissues and organs. Factors such as aging populations, lifestyle changes, environmental exposures, and advancements in detection and diagnostic technologies are contributing to the increasing number of cancer cases. Gene panels play a crucial role in cancer diagnosis by enabling comprehensive genetic testing to identify mutations and alterations in specific genes, facilitating personalized treatment strategies and improving patient outcomes. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that an estimated 9.7 million people died from cancer in 2022, with 20 million new cases recorded. Lung cancer was the most prevalent, accounting for 12.4% of all new cases, with 2.5 million diagnoses worldwide. This increasing cancer burden continues to drive demand for gene panel testing.

Leading companies in the gene panel market are focusing on developing advanced oncology panels to enhance the accuracy, efficiency, and comprehensiveness of cancer diagnostics and personalized treatment approaches. Oncology panels are specialized gene panels that analyze multiple genes associated with cancer, identifying genetic mutations and alterations to aid in diagnosis, prognosis, and treatment planning. For instance, in May 2023, Vizgen Inc., a US-based biotechnology company, introduced the MERFISH PanCancer Pathways Panel, providing a customizable option for scientists exploring spatial genomics. These predesigned panels are optimized for various research applications, including cancer studies, and offer enhanced error robustness for reliable and reproducible results. By integrating spatial information with gene expression data, the panels provide deeper insights into tumor microenvironments and cellular interactions, advancing targeted cancer research and therapeutic development. This innovation marks a significant breakthrough in spatial biology, allowing researchers to analyze complex biological systems with unprecedented detail.

In May 2022, Sema4, a US-based health intelligence company, acquired GeneDx in a $322 million transaction. This acquisition bolsters Sema4's position as a leading provider of genomic testing in the U.S., enhancing its health information database to improve patient care and therapeutic development. GeneDx, also based in the U.S., specializes in comprehensive diagnostic services for rare genetic disorders, inherited diseases, and cancers, further strengthening Sema4's capabilities in precision medicine.

Major players in the gene panel market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Intermountain Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., OPKO Health Inc., Myriad Genetics Inc., Guardant Health Inc., Invitae Corp., Integrated DNA Technologies Inc., Bio-Rad Laboratories Inc., Novogene Corporation, Fulgent Genetics Inc., MedGenome Inc., OriGene Technologies Inc., Centogene AG, Blueprint Genetics Inc., BIONEER Corporation, BGI Group Ltd., Vizgen Inc., Primbio Research Institute LLC.

North America was the largest region in the gene panel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene panel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene panel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene panel market consists of revenues earned by entities by providing services such as custom panel design, next-generation sequencing, bioinformatics analysis, clinical interpretation, and pharmacogenomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene panel market also includes sales of metabolic disorder panels, reproductive health panels, carrier screening panels, and neurological disorder panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Panel Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene panel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene panel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene panel market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Services: Test Kits; Testing Services
  • 2) By Technology: Amplicon-Based; Hybridization-Based; Other Technologies
  • 3) By Design: Predesigned Gene Panel; Customized Gene Panel
  • 4) By Application: Cancer Risk Assessment; Diagnosis Of Congenital Diseases; Pharmacogenetics; Other Applications
  • 5) By End-User: Research Institutes; Hospital; Diagnosis Centers; Pharmaceutical Companies; Other End-Users
  • Subsegments:
  • 1) By Test Kits: Predesigned Gene Panels; Customized Gene Panels
  • 2) By Testing Services: Cancer Risk Assessment Panels; Pharmacogenetic Testing Panels; Neurological Disorder Panels; Cardiovascular Disease Panels; Rare Disease Panels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Intermountain Healthcare; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; Qiagen Inc.; OPKO Health Inc.; Myriad Genetics Inc.; Guardant Health Inc.; Invitae Corp.; Integrated DNA Technologies Inc.; Bio-Rad Laboratories Inc.; Novogene Corporation; Fulgent Genetics Inc.; MedGenome Inc.; OriGene Technologies Inc.; Centogene AG; Blueprint Genetics Inc.; BIONEER Corporation; BGI Group Ltd.; Vizgen Inc.; Primbio Research Institute LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Panel Market Characteristics

3. Gene Panel Market Trends And Strategies

4. Gene Panel Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Panel Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Gene Panel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Gene Panel Market Growth Rate Analysis
  • 5.4. Global Gene Panel Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Gene Panel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Gene Panel Total Addressable Market (TAM)

6. Gene Panel Market Segmentation

  • 6.1. Global Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Kits
  • Testing Services
  • 6.2. Global Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amplicon-Based
  • Hybridization-Based
  • Other Technologies
  • 6.3. Global Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predesigned Gene Panel
  • Customized Gene Panel
  • 6.4. Global Gene Panel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Risk Assessment
  • Diagnosis Of Congenital Diseases
  • Pharmacogenetics
  • Other Applications
  • 6.5. Global Gene Panel Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Institutes
  • Hospital
  • Diagnosis Centers
  • Pharmaceutical Companies
  • Other End-Users
  • 6.6. Global Gene Panel Market, Sub-Segmentation Of Test Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predesigned Gene Panels
  • Customized Gene Panels
  • 6.7. Global Gene Panel Market, Sub-Segmentation Of Testing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Risk Assessment Panels
  • Pharmacogenetic Testing Panels
  • Neurological Disorder Panels
  • Cardiovascular Disease Panels
  • Rare Disease Panels

7. Gene Panel Market Regional And Country Analysis

  • 7.1. Global Gene Panel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Gene Panel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Panel Market

  • 8.1. Asia-Pacific Gene Panel Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Panel Market

  • 9.1. China Gene Panel Market Overview
  • 9.2. China Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Panel Market

  • 10.1. India Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Panel Market

  • 11.1. Japan Gene Panel Market Overview
  • 11.2. Japan Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Panel Market

  • 12.1. Australia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Panel Market

  • 13.1. Indonesia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Panel Market

  • 14.1. South Korea Gene Panel Market Overview
  • 14.2. South Korea Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Panel Market

  • 15.1. Western Europe Gene Panel Market Overview
  • 15.2. Western Europe Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Panel Market

  • 16.1. UK Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Panel Market

  • 17.1. Germany Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Panel Market

  • 18.1. France Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Panel Market

  • 19.1. Italy Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Panel Market

  • 20.1. Spain Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Panel Market

  • 21.1. Eastern Europe Gene Panel Market Overview
  • 21.2. Eastern Europe Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Panel Market

  • 22.1. Russia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Panel Market

  • 23.1. North America Gene Panel Market Overview
  • 23.2. North America Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Panel Market

  • 24.1. USA Gene Panel Market Overview
  • 24.2. USA Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Panel Market

  • 25.1. Canada Gene Panel Market Overview
  • 25.2. Canada Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Panel Market

  • 26.1. South America Gene Panel Market Overview
  • 26.2. South America Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Panel Market

  • 27.1. Brazil Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Panel Market

  • 28.1. Middle East Gene Panel Market Overview
  • 28.2. Middle East Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Panel Market

  • 29.1. Africa Gene Panel Market Overview
  • 29.2. Africa Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Panel Market Competitive Landscape And Company Profiles

  • 30.1. Gene Panel Market Competitive Landscape
  • 30.2. Gene Panel Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Intermountain Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Gene Panel Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. Qiagen Inc.
  • 31.4. OPKO Health Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. Guardant Health Inc.
  • 31.7. Invitae Corp.
  • 31.8. Integrated DNA Technologies Inc.
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. Novogene Corporation
  • 31.11. Fulgent Genetics Inc.
  • 31.12. MedGenome Inc.
  • 31.13. OriGene Technologies Inc.
  • 31.14. Centogene AG
  • 31.15. Blueprint Genetics Inc.

32. Global Gene Panel Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Panel Market

34. Recent Developments In The Gene Panel Market

35. Gene Panel Market High Potential Countries, Segments and Strategies

  • 35.1 Gene Panel Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Gene Panel Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Gene Panel Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer